戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 602159作成日:2026年10月25日

Trifluoroacetic acid → HCID 58992709、化合物

https://huagongshe.com/reaction/602159

反応式

関与物質

役割名称HCID仕込み量
反応物Trifluoroacetic acidHCID 6422—
反応物4-MethylmorpholineHCID 7972—
反応物4-Biphenylcarboxylic acid, 4'-chloro-HCID 616002—
反応物1,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochlorideHCID 2723939—
反応物1-Hydroxybenzotriazole hydrateHCID 2796029—
反応物HCID 58992635HCID 58992635—
溶媒DichloromethaneHCID 6344—
溶媒Ethyl AcetateHCID 8857—
生成物HCID 58992709HCID 5899270971.4%

反応条件

温度0 °C

反応手順

Methyl 2-[3-(tert-butoxycarbonylamino)piperidin-1-yl]benzoate (2.34 g, 7.00 mmol) was dissolved in anhydrous dichloromethane (50 mL). While this solution was ice-chilled and stirred, trifluoroacetic acid (5.2 mL, 6.82 mmol) was added and the mixture was stirred for 3 hours. Subsequently, the reaction mixture was concentrated and a 10% hydrochloric acid/methanol mixture (50 mL) was added to the residue. The mixture was stirred at room temperature for 1 hour and was concentrated. The same process was repeated 3 times and the resulting solid were washed with ethyl acetate. This gave 1.33 g of a colorless powder. This product (113 mg) was dissolved in N,N-dimethylformamide (4 mL). While the solution was chilled to 0° C. and stirred, 4′-chlorobiphenyl-4-carboxylic acid (103 mg, 0.443 mmol), 1-hydroxybenzotriazole monohydrate (63.8 mg, 0.417 mmol), N-methylmorpholine (160 μL, 1.46 mmol) and 3-(3-dimethylaminopropyl)-1-ethylcarbodiimide hydrochloride (78.0 mg, 0.407 mmol) were added. The mixture was stirred at 0° C. for 20 min and at room temperature for the following 6 hours. Subsequently, the reaction mixture was diluted with ethyl acetate. The organic layer washed sequentially with 5% aqueous citric acid, a saturated aqueous sodium bicarbonate solution, water and brine. The washed product was dried over anhydrous sodium sulfate and the solvent was concentrated. Purification of the resulting residue by silica gel column chromatography (hexane:ethyl acetate=3:1) gave 142 mg of the desired compound as colorless crystals.

情報源と証拠

DOI10.6084/m9.figshare.5104873.v1
特許番号US07902367B2
出典データセットuspto-grants-2011_03
ORD IDord-74b666a198c34a96a86e05a81eef2c10
出典メモuspto-grants-2011_03